The human immunodeficiency virus type 1 (HIV-1) long terminal repeat (LTR) represents a
model promoter system and the identification and characterisation of cellular proteins that …

▪ Abstract Lentiviruses are associated with chronic diseases of the hematological and
neurological systems in animals and man. In particular, human immunodeficiency virus type …

Topical microbicides are being sought to prevent sexually transmitted diseases by
inactivating pathogens while preserving or enhancing the natural mucosal barrier. Serious …

Human immunodeficiency virus type-1 (HIV-1) is a highly pathogenic lenti virus that requires
transcription of its provirus genome for completion of the viral life cycle and the production of …

Inflammation of the female reproductive tract increases susceptibility to HIV-1 and other viral
infections and, thus, it becomes a serious liability for vaginal products. Excessive release of …

The current AIDS pandemic represents the uneven spread of multiple genetically related
subtypes (A to J) of human immunodeficiency virus type 1 (HIV-1). Notably, HIV-1 E in …

Human immunodeficiency virus type 1 (HIV-1) has been shown to replicate productively in
cells of the monocyte-macrophage lineage, although replication occurs to a lesser extent …

Co-infection with hepatitis B virus (HBV) and human immunodeficiency virus type-1 (HIV-1)
is relatively common. However, the impact of this co-infection on the clinical outcome of HIV …

The regulation of transcription of the human immunodeficiency virus (HIV) is a complex
event that requires the cooperative action of both viral and cellular components. In latently …

To make human immunodeficiency virus type 1 (HIV-1)-based vectors safer for use in the
research and clinical setting, a significant modification to the HIV-1 genome has been the …